JPH0948782A - New production of 4-desoxy-4'-demethyl-4-epipodophyllotoxin derivative - Google Patents

New production of 4-desoxy-4'-demethyl-4-epipodophyllotoxin derivative

Info

Publication number
JPH0948782A
JPH0948782A JP7199963A JP19996395A JPH0948782A JP H0948782 A JPH0948782 A JP H0948782A JP 7199963 A JP7199963 A JP 7199963A JP 19996395 A JP19996395 A JP 19996395A JP H0948782 A JPH0948782 A JP H0948782A
Authority
JP
Japan
Prior art keywords
general formula
compound
formula
desoxy
demethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7199963A
Other languages
Japanese (ja)
Inventor
Katsuhiko Fujimoto
勝彦 藤本
Kazuo Maruhashi
和夫 丸橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP7199963A priority Critical patent/JPH0948782A/en
Publication of JPH0948782A publication Critical patent/JPH0948782A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To industrially advantageously obtain a compound useful as an antitumor agent with less by-product, free from problem on the safety and sanitation, and without restriction of raw materials by reacting a specific aldehyde compound with an amine in the presence of a specific reductant. SOLUTION: This compound is expressed by formula II and obtained by reacting (a) a compound of formula I (R is H or an OH-protecting group) with (b) a compound of the formula: HN(CH3 )(CH2 )n NR1 R2 (R1 and R2 are each H or a lower alkyl; (n) is 2-6) in the presence of (c) a compound of the formula: H3 B.X [X is a (substituted) monocyclic heterocycle or a group of the formula: NR3 R4 R5 (R3 , R4 and R5 are each H, a lower alkyl or phenyl)].

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、4−デソキシ−
4’−デメチル−4−エピポドフィロトキシン誘導体の
新規製造方法に関し、より詳細には、抗腫瘍剤として有
用である国際特許公開92/12982号公報に記載の
4−デソキシ−4’−デメチル−4−エピポドフィロト
キシン誘導体の新規製造方法に関する。
TECHNICAL FIELD The present invention relates to 4-desoxy-
Regarding a novel method for producing a 4'-demethyl-4-epipodophyllotoxin derivative, more specifically, 4-desoxy-4'-demethyl described in International Patent Publication No. 92/12982, which is useful as an antitumor agent. -4-A novel method for producing an epipodophyllotoxin derivative.

【0002】[0002]

【従来の技術】一般式(4)2. Description of the Related Art General formula (4)

【0003】[0003]

【化3】 Embedded image

【0004】〔式中、Rは水素原子又は水酸基の保護
基、R1 及びR2 は同一又は相異なって水素原子あるい
は低級アルキル基を示し、nは2〜6の整数を示す。〕
で表される4−デソキシ−4’−デメチル−4−エピポ
ドフィロトキシン誘導体の製造方法として、例えば、国
際特許公開92/12982号公報に下記方法が記載さ
れている。
[In the formula, R represents a hydrogen atom or a hydroxyl-protecting group, R 1 and R 2 are the same or different and each represents a hydrogen atom or a lower alkyl group, and n represents an integer of 2 to 6. ]
As a method for producing the 4-desoxy-4′-demethyl-4-epipodophyllotoxin derivative represented by, for example, the following method is described in International Patent Publication No. 92/12982.

【0005】[0005]

【化4】 Embedded image

【0006】〔式中、R1 、R2 及びnは上記と同義、
R′はメチル基、ベンジルオキシカルボニル基、ハロゲ
ン原子を有してもよい低級アルカノイル基又は−Si
(Rx)(Ry)(Rz)基(ここで、Rx、Ry及び
Rzは、同一又は相異なって低級アルキル基又はフェニ
ル基)を示す。〕 即ち上記の方法は、一般式(5)で表される化合物に一
般式(2)で表されるアミンを、不活性溶媒中、水素化
ホウ素ナトリウム又はシアン化水素化ホウ素ナトリウム
の存在下に反応させ、一般式(6)で表される化合物を
得、さらに必要により脱保護して一般式(4)で表され
る化合物中、Rが水素原子である化合物を得る方法であ
る。
[Wherein R 1 , R 2 and n have the same meanings as described above,
R'is a methyl group, a benzyloxycarbonyl group, a lower alkanoyl group which may have a halogen atom, or -Si.
(Rx) (Ry) (Rz) group (wherein Rx, Ry and Rz are the same or different and are lower alkyl groups or phenyl groups). That is, in the above method, the compound represented by the general formula (5) is reacted with the amine represented by the general formula (2) in the presence of sodium borohydride or sodium cyanoborohydride in an inert solvent. A method of obtaining a compound represented by the general formula (6), and further deprotecting it if necessary to obtain a compound represented by the general formula (4) in which R is a hydrogen atom.

【0007】[0007]

【発明が解決しようとする課題】上記の方法ではシアン
化水素化ホウ素ナトリウムを使用しており、この使用は
以下の点で問題があり、工業的製造法としては改良すべ
き点がある。 1)シアン化水素化ホウ素ナトリウムは、猛毒のシアン
化水素を発生させるおそれがあるので、工業的製造にお
いては労働安全衛生上問題があり、その使用を避けた
い。 2)シアン化水素化ホウ素ナトリウムの工業的規模での
入手が困難である。
In the above method, sodium borohydride is used. This use has problems in the following points, and there is a point to be improved as an industrial production method. 1) Since sodium borohydride may generate a highly poisonous hydrogen cyanide, there is a problem in industrial safety in terms of occupational safety and health, and its use should be avoided. 2) It is difficult to obtain sodium borohydride on an industrial scale.

【0008】また、水素化ホウ素ナトリウムは、以下の
理由から実際にはその使用が困難である。 1)水素化ホウ素ナトリウムは強アルカリであるため分
解物を生成しやすいのであらかじめ反応液に酸を添加す
る必要があるが、その際、水素化ホウ素ナトリウムが酸
により分解するため、反応を完全に進行させるためには
理論量以上の水素化ホウ素ナトリウムを必要とする。そ
の上、分解により水素ガスが発生するとともに非常に大
きな発熱が起こり大変危険である。 2)また、1)の方法で反応を行った場合、副生成物の
生成量が多くなる。
Further, sodium borohydride is practically difficult to use for the following reasons. 1) Since sodium borohydride is a strong alkali and easily produces decomposition products, it is necessary to add an acid to the reaction solution in advance. At that time, sodium borohydride is decomposed by the acid, and thus the reaction is completely completed. A theoretical amount of sodium borohydride or more is required to proceed. In addition, hydrogen gas is generated due to decomposition, and a very large amount of heat is generated, which is very dangerous. 2) In addition, when the reaction is performed by the method of 1), the amount of by-products produced increases.

【0009】[0009]

【課題を解決するための手段】本発明者らは、労働安全
衛生上問題がなく、原料的制約も受けずに上記一般式
(4)で表される化合物を工業的に製造する方法につい
て鋭意検討した結果、本発明を完成するに至った。すな
わち、本発明は、一般式(1)
[Means for Solving the Problems] The present inventors have earnestly studied a method for industrially producing a compound represented by the above general formula (4), which has no problems in occupational safety and health and is not restricted by raw materials. As a result of examination, the present invention has been completed. That is, the present invention has the general formula (1)

【0010】[0010]

【化5】 Embedded image

【0011】〔式中、Rは水素原子又は水酸基の保護基
を示す。〕で表わされる4−デソキシ−4’−デメチル
−4−ホルミルメチル−4−エピポドフィロトキシン誘
導体に、一般式(2) HN(CH3 )(CH2 n NR1 2 (2) 〔式中、R1 及びR2 は同一又は相異なって水素原子あ
るいは低級アルキル基を示し、nは2〜6の整数を示
す。〕で表されるアミンを、一般式(3) H3 B・X (3) 〔式中、Xはヘテロ原子で配位する、置換基を有しても
よい単環式複基環又はNR3 4 5 (ここで、R3
4 及びR5 は同一又は相異なって水素原子、低級アル
キル基又はフェニル基を示す。)を示す。〕で表される
還元剤の存在下に反応させることを特徴とする、一般式
(4)
[In the formula, R represents a hydrogen atom or a hydroxyl-protecting group. 4-desoxy-4'-demethyl-4-formylmethyl-4-epipodophyllotoxin derivative represented by] the general formula (2) HN (CH 3) (CH 2) n NR 1 R 2 (2) [In the formula, R 1 and R 2 are the same or different and each represents a hydrogen atom or a lower alkyl group, and n represents an integer of 2 to 6. The amine represented by the formula is represented by the general formula (3) H 3 B · X (3) [wherein, X is a heterocyclic ring which coordinates with a hetero atom, and which may have a substituent or NR. 3 R 4 R 5 (where R 3 ,
R 4 and R 5 are the same or different and each represents a hydrogen atom, a lower alkyl group or a phenyl group. ). ] It reacts in presence of the reducing agent represented by these, General formula (4)

【0012】[0012]

【化6】 [Chemical 6]

【0013】〔式中、R1 、R2 、n及びRは上記と同
義。〕で表される4−デソキシ−4’−デメチル−4−
エピポドフィロトキシン誘導体の製造方法を提供するも
のである。本発明によれば、一般式(4)で表される化
合物を、労働安全衛生上問題のある原材料を使用せずに
製造することができ、工業的製造方法として大きな利点
がある。
[In the formula, R 1 , R 2 , n and R have the same meanings as described above. ] 4-desoxy-4'-demethyl-4- represented by
The present invention provides a method for producing an epipodophyllotoxin derivative. According to the present invention, the compound represented by the general formula (4) can be produced without using a raw material having a problem in occupational safety and health, which is a great advantage as an industrial production method.

【0014】[0014]

【発明の実施の形態】本発明の一般式(1)の化合物に
おいて、Rで示される水酸基の保護基としては、本発明
の反応下で、本発明に用いられる試薬が水酸基と反応し
ないように保護することができ、かつ反応後に除去する
ことができる基であれば特に限定されるものではない。
具体的には、アセチル、ベンゾイル、ピバロイル基等の
アシル基;メトキシカルボニル、エトキシカルボニル、
ベンジルオキシカルボニル基等のアルコキシカルボニル
基;フェノキシカルボニル基等のアリールオキシカルボ
ニル基等の他、メチル、エチル、n−プロピル、イソプ
ロピル、n−ブチル、イソブチル、sec−ブチル、t
ert−ブチル、ペンチル、ネオペンチル、ヘキシル基
等の炭素数1〜6の直鎖状または分枝状のアルキル基;
ベンジル、トリチル基等のアラルキル基が挙げられる。
また、これらの保護基は、さらにハロゲン原子、ニトロ
基、アリールオキシ基、アルコキシ基等の置換基で置換
されていてもよい。上記の中で本発明に用いることがで
きる水酸基の保護基の好ましい例としては、ハロゲン原
子で置換されていてもよいアルコキシカルボニル基が挙
げられ、具体的には、メトキシカルボニル、エトキシカ
ルボニル、ベンジルオキシカルボニル、クロロメトキシ
カルボニル、ジクロロメトキシカルボニル、トリクロロ
メトキシカルボニル、フルオロメトキシカルボニル、ブ
ロモメトキシカルボニル、ヨードメトキシカルボニル、
2−ヨードエトキシカルボニル、2,2−ジクロロエト
キシカルボニル、2,2,2−トリクロロエトキシカル
ボニル、2,2,2−トリブロモエトキシカルボニル基
等が挙げられる。
BEST MODE FOR CARRYING OUT THE INVENTION In the compound of the general formula (1) of the present invention, the protecting group for the hydroxyl group represented by R is such that the reagent used in the present invention does not react with the hydroxyl group under the reaction of the present invention. The group is not particularly limited as long as it can be protected and can be removed after the reaction.
Specifically, acyl groups such as acetyl, benzoyl and pivaloyl groups; methoxycarbonyl, ethoxycarbonyl,
Alkoxycarbonyl group such as benzyloxycarbonyl group; aryloxycarbonyl group such as phenoxycarbonyl group; methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t
ert-butyl, pentyl, neopentyl, hexyl and other linear or branched alkyl groups having 1 to 6 carbon atoms;
Examples thereof include aralkyl groups such as benzyl and trityl groups.
Further, these protecting groups may be further substituted with a substituent such as a halogen atom, a nitro group, an aryloxy group, an alkoxy group and the like. Among the above, preferred examples of the hydroxyl-protecting group that can be used in the present invention include an alkoxycarbonyl group which may be substituted with a halogen atom, and specific examples include methoxycarbonyl, ethoxycarbonyl and benzyloxy. Carbonyl, chloromethoxycarbonyl, dichloromethoxycarbonyl, trichloromethoxycarbonyl, fluoromethoxycarbonyl, bromomethoxycarbonyl, iodomethoxycarbonyl,
Examples thereof include 2-iodoethoxycarbonyl, 2,2-dichloroethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl and 2,2,2-tribromoethoxycarbonyl groups.

【0015】また、本発明の一般式(2)の化合物にお
いて、R1 及びR2 で示される低級アルキル基として
は、例えばメチル、エチル、n−プロピル、イソプロピ
ル、n−ブチル、イソブチル、sec−ブチル、ter
t−ブチル、ペンチル、ネオペンチル、ヘキシル基等の
炭素数1〜6の直鎖状または分枝状のアルキル基が挙げ
られる。一般式(2)の化合物としては、例えば、N,
N−ジエチル−N’−メチルエチレンジアミン、N,
N,N’−トリメチルエチレンジアミン、N,N,N’
−トリメチルプロピレンジアミン、N,N,N’−トリ
メチル−1,6−ヘキサンジアミン等が挙げられる。な
かでも、N,N,N’−トリメチルエチレンジアミンが
好ましい。
In the compound of the general formula (2) of the present invention, the lower alkyl group represented by R 1 and R 2 is, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec- Butyl, ter
Examples thereof include linear or branched alkyl groups having 1 to 6 carbon atoms such as t-butyl, pentyl, neopentyl and hexyl groups. Examples of the compound of the general formula (2) include N,
N-diethyl-N'-methylethylenediamine, N,
N, N'-trimethylethylenediamine, N, N, N '
-Trimethylpropylenediamine, N, N, N'-trimethyl-1,6-hexanediamine and the like can be mentioned. Among them, N, N, N'-trimethylethylenediamine is preferable.

【0016】本発明の一般式(3)の化合物において、
Xで示される単環式複素環としては、ヘテロ原子として
窒基原子、酸素原子又は硫黄原子を1〜3個有する5又
は6員の複素環が好ましく、例えばピリジン、ピリダジ
ン、ピリミジン、ピラジン、ピロール、イミダゾール、
ピペリジン、ピペラジン、ピロリジン、モルホリン、テ
トラハイドロフラン、オキサチアン等が挙げられる。な
かでも、ピリジン、ピペリジン、ピペラジン、モルホリ
ン、テトラハイドロフラン、オキサチアン等が好まし
く、ピリジンがより好ましい。これらの単環式複素環が
有していてもよい置換基としては、例えば、低級アルキ
ル基、ジ低級アルキルアミノ基、フェニル基等が挙げら
れ、低級アルキル基としては、R1 及びR2 で例示した
低級アルキル基が挙げられ、ジ低級アルキルアミノ基と
しては、ジメチルアミノ、ジエチルアミノ、ジプロピル
アミノ、ジブチルアミノ、ジメチルエチルアミノ、ジメ
チルプロピルアミノ、ジエチルプロピルアミノ基等が挙
げられる。また、一般式(3)の化合物において、R3
〜R5 で示される低級アルキル基としては、上記低級ア
ルキル基と同様のものが挙げられる。
In the compound of the general formula (3) of the present invention,
The monocyclic heterocycle represented by X is preferably a 5- or 6-membered heterocycle having 1 to 3 nitrogen atom, oxygen atom or sulfur atom as a hetero atom, and examples thereof include pyridine, pyridazine, pyrimidine, pyrazine and pyrrole. , Imidazole,
Examples thereof include piperidine, piperazine, pyrrolidine, morpholine, tetrahydrofuran and oxathian. Among them, pyridine, piperidine, piperazine, morpholine, tetrahydrofuran, oxathian and the like are preferable, and pyridine is more preferable. Examples of the substituent which these monocyclic heterocycles may have include a lower alkyl group, a di-lower alkylamino group and a phenyl group. Examples of the lower alkyl group include R 1 and R 2 . Examples thereof include lower alkyl groups, and examples of di-lower alkylamino groups include dimethylamino, diethylamino, dipropylamino, dibutylamino, dimethylethylamino, dimethylpropylamino and diethylpropylamino groups. Further, in the compound of the general formula (3), R 3
Examples of the lower alkyl group represented by R 5 to R 5 include the same as the above lower alkyl groups.

【0017】一般式(3)で示される化合物におけるX
の具体例としては、N,N−ジエチルアニリン、ピリジ
ン、4−ジメチルアミノピリジン、2,6−ルチジン、
ピペリジン、ピペラジン、モルホリン、4−メチルモル
ホリン、4−エチルモルホリン、4−フェニルモルホリ
ン、1,4−オキサチアン等;及びアンモニア、ter
t−ブチルアミン、ジメチルアミン、ジエチルアミン、
トリメチルアミン、トリエチルアミン、N,N−ジイソ
プロピルエチルアミン等が挙げられる。なかでも、ピリ
ジン、トリメチルアミン又はトリエチルアミンが好まし
い。
X in the compound represented by the general formula (3)
Specific examples of N, N-diethylaniline, pyridine, 4-dimethylaminopyridine, 2,6-lutidine,
Piperidine, piperazine, morpholine, 4-methylmorpholine, 4-ethylmorpholine, 4-phenylmorpholine, 1,4-oxathiane, etc .; and ammonia, ter
t-butylamine, dimethylamine, diethylamine,
Examples include trimethylamine, triethylamine, N, N-diisopropylethylamine and the like. Of these, pyridine, trimethylamine or triethylamine is preferable.

【0018】本発明における一般式(1)の化合物は、
例えば、前記国際特許公開92/12982号公報に記
載の方法で得ることができる。また、一般式(3)の化
合物としては、一般に市販されているものを用いること
ができ、市販品以外の化合物でも、例えば、J. Am. Che
m. Soc., 81, 4791(1959) 又はOrganic Reaction vol.5
5 p30に記載の方法で製造することができる。つまり、
一般式(3)の化合物、ボランーアミン錯体は上記の既
知の方法により、得ようとするボランーアミン錯体に対
応するアミン化合物、金属ホウ素化合物(金属としては
ナトリウム、リチウム等)及び酸(鉱酸又はルイス酸)
から容易に製造することができる。
The compound of the general formula (1) in the present invention is
For example, it can be obtained by the method described in International Patent Publication No. 92/12982. Further, as the compound of the general formula (3), those which are generally commercially available can be used, and even compounds other than the commercially available products can be used, for example, J. Am. Che.
m. Soc., 81, 4791 (1959) or Organic Reaction vol.5
5 It can be produced by the method described in p30. That is,
The compound of the general formula (3) and the borane-amine complex are amine compounds corresponding to the borane-amine complex to be obtained, a metal boron compound (as a metal, sodium, lithium, etc.) and an acid (a mineral acid or a Lewis acid) by the above-mentioned known method. )
Can be easily manufactured.

【0019】本発明の方法における反応は適当な溶媒中
で行うことが好ましい。溶媒としては、反応に影響を及
ぼさない限り制限はなく、例えば、メタノール、エタノ
ール、イソプロパノール等のアルコール類、ジクロロメ
タン、ジクロロエタン等のハロゲン化炭化水素類、アセ
トニトリル、水、酢酸、蟻酸等を単一もしくは混合して
使用することができる。
The reaction in the method of the present invention is preferably carried out in a suitable solvent. The solvent is not limited as long as it does not affect the reaction, for example, methanol, ethanol, alcohols such as isopropanol, dichloromethane, halogenated hydrocarbons such as dichloroethane, acetonitrile, water, acetic acid, formic acid and the like alone or It can be mixed and used.

【0020】一般式(2)で示される化合物の使用量
は、一般式(1)の化合物に対して1当量以上あればよ
く、好ましくは1〜1.5当量である。一般式(3)で
示される還元剤の使用量は、一般式(1)の化合物に対
して0.3〜3当量、好ましくは0.5〜1当量であ
る。反応温度としては0〜60℃、好ましくは10〜5
0℃である。反応時間は、反応温度、反応試薬等によっ
て異なるが、一般に数時間〜48時間である。
The amount of the compound represented by the general formula (2) used may be 1 equivalent or more, preferably 1 to 1.5 equivalents, relative to the compound of the general formula (1). The amount of the reducing agent represented by the general formula (3) used is 0.3 to 3 equivalents, preferably 0.5 to 1 equivalents, relative to the compound of the general formula (1). The reaction temperature is 0 to 60 ° C., preferably 10 to 5
0 ° C. The reaction time varies depending on the reaction temperature, the reaction reagent, etc., but is generally several hours to 48 hours.

【0021】また、反応液に、有機酸又は鉱酸を共存さ
せることも可能であり、有機酸としては、酢酸、蟻酸等
が、鉱酸としては塩酸、硫酸等が挙げられる。さらに、
本発明で得られた一般式(4)の化合物は、適当な溶媒
に溶解し、塩酸を加えるか又は塩化水素ガスを吹き込む
ことにより塩酸塩の結晶として得ることができる。この
反応の溶媒としては、メタノール、エタノール、イソプ
ロパノール等のアルコール類、ジクロロメタン、ジクロ
ロエタン等のハロゲン化炭化水素類、アセトン、メチル
エチルケトン等のケトン類、アセトニトリル、水等を単
独もしくは混合して使用することができる。
It is also possible to allow an organic acid or a mineral acid to coexist in the reaction solution. Examples of the organic acid include acetic acid and formic acid, and examples of the mineral acid include hydrochloric acid and sulfuric acid. further,
The compound of the general formula (4) obtained in the present invention can be obtained as a hydrochloride salt crystal by dissolving in a suitable solvent and adding hydrochloric acid or blowing hydrogen chloride gas. As a solvent for this reaction, alcohols such as methanol, ethanol and isopropanol, halogenated hydrocarbons such as dichloromethane and dichloroethane, ketones such as acetone and methyl ethyl ketone, acetonitrile and water may be used alone or in combination. it can.

【0022】一般式(4)の化合物のうち、Rが水酸基
の保護基の場合には、保護基の種類によって、当該分野
で公知の方法を利用して、保護基を除去することができ
る。例えば、保護基がベンジルオキシカルボニル基又は
ベンジル基の場合には、不活性溶媒(例:酢酸エチル、
メタノール、テトラヒドロフラン、アセトニトリル等の
単独又は混合溶媒)中、触媒の存在下に接触還元するこ
とにより、脱保護した化合物を得ることができる。不活
性溶媒としては反応に関与しないものであれば特に限定
されるものではない。触媒としては、例えばパラジウム
黒、白金等を使用することができる。その際の水素圧は
常圧〜3気圧程度、さらに常圧〜2気圧程度が好まし
く、反応温度は0〜40℃程度、さらに室温程度が好ま
しい。
When R is a hydroxyl-protecting group in the compound of formula (4), the protecting group can be removed by a method known in the art depending on the kind of the protecting group. For example, when the protecting group is a benzyloxycarbonyl group or a benzyl group, an inert solvent (eg ethyl acetate,
The deprotected compound can be obtained by catalytic reduction in the presence of a catalyst in methanol, tetrahydrofuran, acetonitrile or the like (single or mixed solvent). The inert solvent is not particularly limited as long as it does not participate in the reaction. As the catalyst, for example, palladium black, platinum or the like can be used. At that time, the hydrogen pressure is preferably atmospheric pressure to 3 atm, more preferably atmospheric pressure to 2 atm, and the reaction temperature is preferably 0 to 40 ° C., more preferably room temperature.

【0023】本発明の製造方法によって得られる化合物
は、濃縮、抽出、結晶化、再結晶等の通常の精製方法に
より容易に精製することができる。
The compound obtained by the production method of the present invention can be easily purified by conventional purification methods such as concentration, extraction, crystallization and recrystallization.

【0024】[0024]

【実施例】以下に本発明を実施例を挙げて詳細に説明す
る。 実施例1 4−デソキシ−4’−デメチル−4−(2−(2−ジメ
チルアミノエチル)メチルアミノエチル)−4−エピポ
ドフィロトキシンの合成 4−デソキシ−4’−デメチル−4−ホルミルメチル−
4−エピポドフィロトキシン1.0g(2.34mmo
l)のメタノール(25ml)懸濁液に99%蟻酸
(0.5ml)を加え、約5℃まで冷却した。N,N,
N’−トリメチルエチレンジアミン240mg(2.3
5mmol)のメタノール(5ml)溶液及びトリメチ
ルアミンボラン205mg(2.81mmol)を加
え、約40℃で24時間反応した。
EXAMPLES The present invention will be described in detail below with reference to examples. Example 1 Synthesis of 4-desoxy-4'-demethyl-4- (2- (2-dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin 4-desoxy-4'-demethyl-4-formyl Methyl-
1.0 g of 4-epipodophyllotoxin (2.34 mmo
99% Formic acid (0.5 ml) was added to a suspension of l) in methanol (25 ml), and the mixture was cooled to about 5 ° C. N, N,
240 mg of N'-trimethylethylenediamine (2.3
A solution of 5 mmol) in methanol (5 ml) and 205 mg (2.81 mmol) of trimethylamine borane were added, and the mixture was reacted at about 40 ° C. for 24 hours.

【0025】反応液を減圧濃縮して得られた残渣に水2
0ml及び酢酸エチル10mlを加え、30分間撹拌し
た。水層を分取し、酢酸エチル10mlを加え、30分
間撹拌した。分層し得られた水層を約5℃に冷却し、2
N−水酸化ナトリウム水溶液をpH8.9になるまで滴
下しながら撹拌した。ついで、4−デソキシ−4’−デ
メチル−4−(2−(2−ジメチルアミノエチル)メチ
ルアミノエチル)−4−エピポドフィロトキシン50m
gを種晶として加え、約5℃で1時間撹拌した。析出し
た結晶をろ取し、水(5ml×3)で洗浄後、約40℃
で減圧乾燥し、4−デソキシ−4’−デメチル−4−
(2−(2−ジメチルアミノエチル)メチルアミノエチ
ル)−4−エピポドフィロトキシン0.91g(収率7
5.8%)を白色粉末として得た。
The reaction mixture was concentrated under reduced pressure and the residue obtained was diluted with water 2.
0 ml and 10 ml of ethyl acetate were added and stirred for 30 minutes. The aqueous layer was separated, 10 ml of ethyl acetate was added, and the mixture was stirred for 30 minutes. The resulting aqueous layer was separated and cooled to about 5 ° C.
The N-sodium hydroxide aqueous solution was stirred while being added dropwise until the pH became 8.9. Then, 4-desoxy-4′-demethyl-4- (2- (2-dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin 50 m
g was added as a seed crystal, and the mixture was stirred at about 5 ° C for 1 hour. The precipitated crystals were collected by filtration, washed with water (5 ml x 3), and then washed at about 40 ° C.
And dried under reduced pressure with 4-desoxy-4'-demethyl-4-.
(2- (2-Dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin 0.91 g (yield 7
5.8%) was obtained as a white powder.

【0026】1H-NMR(DMSO-d6;TMS):δ 6.86 (1H, s), 6.42 (1H, s), 6.20 (2H, s), 5.96 (1
H, d, J=0.7Hz), 5.95(1H, d, J=0.7Hz), 4.41 (1H, d,
J=5.6Hz), 4.35 (1H, t, J=8Hz), 4.07 (1H,dd, J=8,1
1Hz), 3.62 (6H, s), 3.09 〜3.19 (2H, m), 2.87 (1H,
m), 2.26〜2.48 (6H, m), 2.18 (3H, s), 2.06 (6H,
s), 1.90〜2.06 (1H, m), 1.45〜1.52 (1H, m)
1 H-NMR (DMSO-d 6 ; TMS): δ 6.86 (1H, s), 6.42 (1H, s), 6.20 (2H, s), 5.96 (1
H, d, J = 0.7Hz), 5.95 (1H, d, J = 0.7Hz), 4.41 (1H, d,
J = 5.6Hz), 4.35 (1H, t, J = 8Hz), 4.07 (1H, dd, J = 8,1
1Hz), 3.62 (6H, s), 3.09 to 3.19 (2H, m), 2.87 (1H,
m), 2.26 ~ 2.48 (6H, m), 2.18 (3H, s), 2.06 (6H,
s), 1.90 ~ 2.06 (1H, m), 1.45 ~ 1.52 (1H, m)

【0027】つぎに、得られた4−デソキシ−4’−デ
メチル−4−(2−(2−ジメチルアミノエチル)メチ
ルアミノエチル)−4−エピポドフィロトキシン700
mg(1.37mmol)をアセトン6.6ml及び水
0.4mlに溶解し、ろ過により不溶物を除き、さら
に、アセトン4.95ml及び水0.3mlで洗浄後、
ろ液及び洗液を合し、約5℃に冷却した。冷却液に6N
−塩酸水0.46ml(2.76mmol)を滴下し、
約5℃で1時間撹拌した。結晶をろ取し、アセトン14
mlで洗浄後、約40℃で減圧乾燥し、標記化合物の塩
酸塩562mg(収率70.6%)を白色結晶として得
た。
Next, the obtained 4-desoxy-4'-demethyl-4- (2- (2-dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin 700 was obtained.
mg (1.37 mmol) was dissolved in 6.6 ml of acetone and 0.4 ml of water, insoluble matter was removed by filtration, and further washed with 4.95 ml of acetone and 0.3 ml of water,
The filtrate and washings were combined and cooled to about 5 ° C. 6N for cooling liquid
-Add 0.46 ml (2.76 mmol) of hydrochloric acid water dropwise,
The mixture was stirred at about 5 ° C for 1 hour. The crystals are collected by filtration and acetone 14
After washing with ml, the residue was dried under reduced pressure at about 40 ° C. to obtain 562 mg (yield 70.6%) of the hydrochloride of the title compound as white crystals.

【0028】1H-NMR(DMSO-d6;TMS):δ 7.05 (1H, s), 6.46 (1H, s), 6.20 (2H, s), 5.98 (2
H, d), 4.45 (1H, d),4.37 (1H, t), 4.18 (1H, m), 3.
62 (6H, s), 3.38〜3.58 (6H, br), 3.13 〜3.20 (2H,
m), 2.94 (1H, m), 2.83 (6H, s), 2.81 (3H, s), 2.33
(1H, m), 1.91(1H, m)
1 H-NMR (DMSO-d 6 ; TMS): δ 7.05 (1H, s), 6.46 (1H, s), 6.20 (2H, s), 5.98 (2
H, d), 4.45 (1H, d), 4.37 (1H, t), 4.18 (1H, m), 3.
62 (6H, s), 3.38 ~ 3.58 (6H, br), 3.13 ~ 3.20 (2H,
m), 2.94 (1H, m), 2.83 (6H, s), 2.81 (3H, s), 2.33
(1H, m), 1.91 (1H, m)

【0029】実施例2 4−デソキシ−4’−デメチル−4−(2−(2−ジメ
チルアミノエチル)メチルアミノエチル)−4−エピポ
ドフィロトキシンの合成 4−デソキシ−4’−デメチル−4−ホルミルメチル−
4−エピポドフィロトキシン1.0g(2.34mmo
l)のメタノール(25ml)懸濁液に99%蟻酸
(0.5ml)を加え、約5℃まで冷却した。N,N,
N’−トリメチルエチレンジアミン240mg(2.3
5mmol)のメタノール(3ml)溶液及びトリエチ
ルアミンボラン323mg(2.80mmol)のメタ
ノール(3ml)溶液を加え、約20℃で24時間反応
した。
Example 2 Synthesis of 4-desoxy-4'-demethyl-4- (2- (2-dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin 4-desoxy-4'-demethyl- 4-formylmethyl-
1.0 g of 4-epipodophyllotoxin (2.34 mmo
99% Formic acid (0.5 ml) was added to a suspension of l) in methanol (25 ml), and the mixture was cooled to about 5 ° C. N, N,
240 mg of N'-trimethylethylenediamine (2.3
A solution of 5 mmol) of methanol (3 ml) and a solution of 323 mg (2.80 mmol) of triethylamine borane in methanol (3 ml) were added, and the mixture was reacted at about 20 ° C. for 24 hours.

【0030】反応液を減圧濃縮して得られた残渣に水2
0ml及び酢酸エチル10mlを加え、30分間撹拌し
た。水層を分取し、酢酸エチル10mlを加え、30分
間撹拌した。分層し得られた水層を約5℃に冷却し、2
N−水酸化ナトリウム水溶液をpH8.9になるで滴下
しながら撹拌し、約5℃で1時間撹拌した。析出した結
晶をろ取し、水(5ml×3)で洗浄後、約40℃で減
圧乾燥し、4−デソキシ−4’−デメチル−4−(2−
(2−ジメチルアミノエチル)メチルアミノエチル)−
4−エピポドフィロトキシン0.75g(収率62.5
%)を白色粉末として得た。NMRの値は実施例1で得
られたものと一致した。
The reaction mixture was concentrated under reduced pressure, and the residue obtained was mixed with water (2).
0 ml and 10 ml of ethyl acetate were added and stirred for 30 minutes. The aqueous layer was separated, 10 ml of ethyl acetate was added, and the mixture was stirred for 30 minutes. The resulting aqueous layer was separated and cooled to about 5 ° C.
The aqueous solution of N-sodium hydroxide was stirred while dropping to pH 8.9 and stirred at about 5 ° C. for 1 hour. The precipitated crystals were collected by filtration, washed with water (5 ml × 3), dried under reduced pressure at about 40 ° C., and 4-desoxy-4′-demethyl-4- (2-
(2-Dimethylaminoethyl) methylaminoethyl)-
0.75 g of 4-epipodophyllotoxin (yield 62.5
%) As a white powder. The NMR values were in agreement with those obtained in Example 1.

【0031】実施例3 4−デソキシ−4’−デメチル−4−(2−(2−ジメ
チルアミノエチル)メチルアミノエチル)−4−エピポ
ドフィロトキシンの合成 4−デソキシ−4’−デメチル−4−ホルミルメチル−
4−エピポドフィロトキシン1.0g(2.34mmo
l)のメタノール(25ml)懸濁液に99%蟻酸
(0.5ml)を加え、約5℃まで冷却した。N,N,
N’−トリメチルエチレンジアミン240mg(2.3
5mmol)のメタノール(3ml)溶液及びピリジン
ボラン260mg(2.80mmol)のメタノール
(3ml)溶液を加え、約20℃で24時間反応した。
Example 3 Synthesis of 4-desoxy-4'-demethyl-4- (2- (2-dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin 4-desoxy-4'-demethyl- 4-formylmethyl-
1.0 g of 4-epipodophyllotoxin (2.34 mmo
99% Formic acid (0.5 ml) was added to a suspension of l) in methanol (25 ml), and the mixture was cooled to about 5 ° C. N, N,
240 mg of N'-trimethylethylenediamine (2.3
A solution of 5 mmol) of methanol (3 ml) and a solution of 260 mg (2.80 mmol) of pyridineborane in methanol (3 ml) were added, and the mixture was reacted at about 20 ° C. for 24 hours.

【0032】反応液を減圧濃縮して得られた残渣に水2
0ml及び酢酸エチル10mlを加え、30分間撹拌し
た。水層を分取し、酢酸エチル(10ml)を加え、3
0分間撹拌した。分層して得られた水層を約5℃に冷却
し、2N−水酸化ナトリウム水溶液をpH8.9になる
まで滴下しながら撹拌し、約5℃で1時間撹拌した。析
出した結晶をろ取し、水(5ml×3)で洗浄後、約4
0℃で減圧乾燥し、4−デソキシ−4’−デメチル−4
−(2−(2−ジメチルアミノエチル)メチルアミノエ
チル)−4−エピポドフィロトキシン1.02g(収率
84.8%)を白色粉体として得た。NMRの値は実施
例1で得られたものと一致した。
The residue obtained by concentrating the reaction solution under reduced pressure was diluted with water 2.
0 ml and 10 ml of ethyl acetate were added and stirred for 30 minutes. The aqueous layer was separated, ethyl acetate (10 ml) was added, and the mixture was added to 3
Stir for 0 minutes. The aqueous layer obtained by separating the layers was cooled to about 5 ° C., and the mixture was stirred while dropping a 2N-sodium hydroxide aqueous solution until the pH reached 8.9, and stirred at about 5 ° C. for 1 hour. The precipitated crystals were collected by filtration, washed with water (5 ml x 3), and then washed with about 4
After drying under reduced pressure at 0 ° C., 4-desoxy-4′-demethyl-4
1.02 g (yield 84.8%) of-(2- (2-dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin was obtained as a white powder. The NMR values were in agreement with those obtained in Example 1.

【0033】実施例4 4−デソキシ−4’−デメチル−4−(2−(2−ジメ
チルアミノエチル)メチルアミノエチル)−4−エピポ
ドフィロトキシンの合成 4−デソキシ−4’−デメチル−4−ホルミルメチル−
4−エピポドフィロトキシン40.0g(93.8mm
ol)のメタノール(200ml)及び90%蟻酸
(4.0ml)懸濁液に約25℃でN,N,N’−トリ
メチルエチレンジアミン10.7g(103.1mmo
l)のメタノール(120ml)溶液及びピリジンボラ
ン4.5g(47.0mmol)のメタノール(80m
l)溶液を加え、約25℃で3〜5時間反応した。
Example 4 Synthesis of 4-desoxy-4'-demethyl-4- (2- (2-dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin 4-desoxy-4'-demethyl- 4-formylmethyl-
40.0 g of 4-epipodophyllotoxin (93.8 mm
ol) in methanol (200 ml) and 90% formic acid (4.0 ml) at about 25 ° C. in N, N, N′-trimethylethylenediamine 10.7 g (103.1 mmo).
1) in methanol (120 ml) and pyridine borane (4.5 g, 47.0 mmol) in methanol (80 m).
1) The solution was added and the reaction was carried out at about 25 ° C. for 3 to 5 hours.

【0034】反応後にホルマリン12.3mlを加え、
約23℃で1時間撹拌後、反応液を減圧濃縮して得られ
た残渣に1M−蟻酸水400mlを加え、室温で一夜放
置した。酢酸エチル400mlを加え、30分間撹拌
し、水層を分取し、さらに酢酸エチル400mlを加
え、30分間撹拌した。分層して得られた水層を約5℃
に冷却し、2N−水酸化ナトリウム水溶液をpH約8.
0になるまで滴下しながら撹拌し、ついで、4−デソキ
シ−4’−デメチル−4(2−(2−ジメチルアミノエ
チル)メチルアミノエチル)−4−エピポドフィロトキ
シン400mgを種晶として加えた後、2N−水酸化ナ
トリウム水溶液をpH約8.9になるまで滴下しなが
ら、撹拌した。約5℃で1時間撹拌した。析出した結晶
をろ取し、水(200ml×3)で洗浄後、約40℃で
減圧乾燥し、4−デソキシ−4’−デメチル−4−(2
−(2−ジメチルアミノエチル)メチルアミノエチル)
−4−エピポドフィロトキシン44.3g(収率85.
9%)を白色粉末として得た。NMRの値は実施例1で
得られたものと一致した。
After the reaction, 12.3 ml of formalin was added,
After stirring at about 23 ° C. for 1 hour, the reaction mixture was concentrated under reduced pressure, 400 ml of 1M aqueous formic acid was added to the obtained residue, and the mixture was left at room temperature overnight. 400 ml of ethyl acetate was added and the mixture was stirred for 30 minutes, the aqueous layer was separated, 400 ml of ethyl acetate was further added, and the mixture was stirred for 30 minutes. Water layer obtained by layer separation is about 5 ℃
And cooled to 2N-sodium hydroxide aqueous solution to a pH of about 8.
The mixture was stirred until it reached 0, and then 400 mg of 4-desoxy-4′-demethyl-4 (2- (2-dimethylaminoethyl) methylaminoethyl) -4-epipodophyllotoxin was added as a seed crystal. Then, the mixture was stirred while adding a 2N-sodium hydroxide aqueous solution dropwise until the pH reached about 8.9. The mixture was stirred at about 5 ° C for 1 hour. The precipitated crystals were collected by filtration, washed with water (200 ml × 3), dried under reduced pressure at about 40 ° C., and then 4-desoxy-4′-demethyl-4- (2
-(2-Dimethylaminoethyl) methylaminoethyl)
-4-Epipodophyllotoxin 44.3 g (yield 85.
9%) as a white powder. The NMR values were in agreement with those obtained in Example 1.

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 一般式(1) 【化1】 〔式中、Rは水素原子又は水酸基の保護基を示す。〕で
表わされる4−デソキシ−4’−デメチル−4−ホルミ
ルメチル−4−エピポドフィロトキシン誘導体に、一般
式(2) HN(CH3 )(CH2 n NR1 2 (2) 〔式中、R1 及びR2 は同一又は相異なって水素原子あ
るいは低級アルキル基を示し、nは2〜6の整数を示
す。〕で表わされるアミンを、一般式(3) H3 B・X (3) 〔式中、Xはヘテロ原子で配位する、置換基を有しても
よい単環式複素環又はNR3 4 5 (ここで、R3
4 及びR5 は同一又は相異なって水素原子、低級アル
キル基又はフェニル基を示す。)を示す。〕で表される
還元剤の存在下に反応させることを特徴とする、一般式
(4) 【化2】 〔式中、R1 、R2 、n及びRは上記と同義。〕で表さ
れる4−デソキシ−4’−デメチル−4−エピポドフィ
ロトキシン誘導体の製造方法。
1. A compound represented by the general formula (1): [In the formula, R represents a hydrogen atom or a protective group for a hydroxyl group. 4-desoxy-4'-demethyl-4-formylmethyl-4-epipodophyllotoxin derivative represented by] the general formula (2) HN (CH 3) (CH 2) n NR 1 R 2 (2) [In the formula, R 1 and R 2 are the same or different and each represents a hydrogen atom or a lower alkyl group, and n represents an integer of 2 to 6. And an amine represented by the general formula (3) H 3 B · X (3) [wherein, X is a heterocyclic ring optionally coordinated with a hetero atom or NR 3 R 4 R 5 (where R 3 ,
R 4 and R 5 are the same or different and each represents a hydrogen atom, a lower alkyl group or a phenyl group. ). ] The reaction is carried out in the presence of a reducing agent represented by the general formula (4): [In the formula, R 1 , R 2 , n and R are as defined above. ] The manufacturing method of the 4-desoxy-4'-demethyl-4-epipodophyllotoxin derivative represented by these.
【請求項2】 Rが水素原子である請求項1記載の製造
方法。
2. The production method according to claim 1, wherein R is a hydrogen atom.
【請求項3】 一般式(2)で表されるアミンが、N,
N,N’−トリメチルエチレンジアミンである請求項1
又は2記載の製造方法。
3. The amine represented by the general formula (2) is N,
2. N, N'-trimethylethylenediamine.
Or the manufacturing method according to 2.
【請求項4】 Xの単環式複素環がピリジンである請求
項1〜3のいずれかに記載の製造方法。
4. The production method according to claim 1, wherein the monocyclic heterocycle of X is pyridine.
【請求項5】 Xがトリメチルアミン、トリエチルアミ
ン又はピリジンである請求項1〜3のいずれかに記載の
製造方法。
5. The production method according to claim 1, wherein X is trimethylamine, triethylamine or pyridine.
JP7199963A 1995-08-04 1995-08-04 New production of 4-desoxy-4'-demethyl-4-epipodophyllotoxin derivative Pending JPH0948782A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7199963A JPH0948782A (en) 1995-08-04 1995-08-04 New production of 4-desoxy-4'-demethyl-4-epipodophyllotoxin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7199963A JPH0948782A (en) 1995-08-04 1995-08-04 New production of 4-desoxy-4'-demethyl-4-epipodophyllotoxin derivative

Publications (1)

Publication Number Publication Date
JPH0948782A true JPH0948782A (en) 1997-02-18

Family

ID=16416523

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7199963A Pending JPH0948782A (en) 1995-08-04 1995-08-04 New production of 4-desoxy-4'-demethyl-4-epipodophyllotoxin derivative

Country Status (1)

Country Link
JP (1) JPH0948782A (en)

Similar Documents

Publication Publication Date Title
JP3421354B2 (en) Crystalline cefdiniramine salt
Krowicki et al. Synthesis of novel imidazole-containing DNA minor groove binding oligopeptides related to the antiviral antibiotic netropsin
EP0874853A1 (en) Process for preparation of cefdinir
Nativ et al. 2‐Azabicyclo [3.2. 0] Heptane‐3‐One
JP2018507858A (en) Process for the preparation of topiroxostat and its intermediates
JPH07285922A (en) Production of glutamine derivative
WO2007091391A1 (en) Improved method for producing nitroguanidine derivative
RU2198176C2 (en) Methods of synthesis of azasteroid derivatives, derivative of azasteroid-imidazolide, method of its synthesis
JPH0948782A (en) New production of 4-desoxy-4'-demethyl-4-epipodophyllotoxin derivative
JP2023547282A (en) Method for selectively synthesizing 3,6'-dithiopomalidomide from pomalidomide
JP3018185B1 (en) Method for producing quinazoline derivative or salt thereof
JPH026450A (en) Production of oxalyl-or oxamyl-hydrazide
CN113200902B (en) Polysubstituted pyrrole derivative and preparation method thereof
US6723844B1 (en) Preparation of K-252a
JPS61263995A (en) Production of cytosine nucleoside
US5648490A (en) Process for the preparation of 5-formylaminopyrimidines
US4897495A (en) Process for the preparation of pyrrolizine derivatives
US4985569A (en) Pyrrolizine derivative and its manufacture
KR20230174902A (en) Preparation for Benzoamine derivatives
JP4587139B2 (en) A method for producing an aminoalkoxycarbostyril derivative.
JPH09110831A (en) Production of 2,2'-bisindole derivative
JPH07267950A (en) Production of 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazole-4-amine or its acid-added salt
KR790001070B1 (en) Process for preparing cephalosporin
WO1999052912A1 (en) PROCESS FOR PRODUCING HALOGENATED β-LACTAM COMPOUND
CN118324683A (en) Preparation method of 3-chloro-2-oxo- [1,3'] bipyrrolidinyl-1' -carboxylic acid allyl ester

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050118

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050316

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050927